Metronomic dosing of ovarian cancer cells with the ATR inhibitor AZD6738 leads to loss of CDC25A expression and resistance to ATRi treatment
- Resource Type
- Article
- Authors
- Ao, Wei; Kim, Hong Im; Tommarello, Domenic; Conrads, Kelly A.; Hood, Brian L.; Litzi, Tracy; Abulez, Tamara; Teng, Pang-Ning; Dalgard, Clifton L.; Zhang, Xijun; Wilkerson, Matthew D.; Darcy, Kathleen M.; Tarney, Christopher M.; Phippen, Neil T.; Bakkenist, Christopher J.; Maxwell, G. Larry; Conrads, Thomas P.; Risinger, John I.; Bateman, Nicholas W.
- Source
- In Gynecologic Oncology October 2023 177:60-71
- Subject
- Language
- ISSN
- 0090-8258